CGRP Forum is made possible thanks to support from AbbVie, Lilly, Organon and Pfizer, all of whom have no influence or control of editorial content. More information is available here »

Positive data reported for eptinezumab in Sunrise trial New insights on treatment holidays with erenumab Dual CGRP ligand mAb and gepant therapy reduces headache severity CGRP-mAb switching yields migraine day reduction Lower switching rates with atogepant than CGRP mAbs EMBRACE shows erenumab reduces migraine severity Older patients benefit from CGRP mAbs too DELIVER shows long term QoL benefits with eptinezumab

Professor Lars Edvinsson MD, PhD

Editorial Board

Professor in Internal Medicine, Faculty of Medicine

Department of Medicine, Institute of Clinical Sciences, Lund University Hospital, Sweden

Professor Edvinsson is a leading expert in the field of cerebral circulation. He is world-recognised for his work on vascular innervation and receptor regulation. His extensive research has been a major contributor to what is known about the roles of the cerebral vasculature in health and diseases such as stroke and primary headaches. He has written a major textbook in the field; Cerebral Blood Flow & Metabolism (1993 Raven Press, 2002 Lippincott Williams Wilkins).

« Back to Editorial Board

Disclosures

Professor Edvinsson declares the following:

Research projects and student support have been continuously funded since 1975. In Sweden the Research council (current 2015-2019, 1500 KSEK/y), Heart-Lung foundation, and FAMRI, USA (K$ 110/y).

Current research and student support at Glostrup Research Institute funded by grants from the

Danish Medical Research Council; Danish Agency for Science, Technology and Innovation;

The Lundbeck Foundation with two major grants (the LUCENS group 2005-2014; Center of

Excellence in Stroke 2011-2016), and Novo Nordisk Foundation.

Articles by Lars Edvinsson

Educational Partners and Supporters

This program is funded in part via an independent educational grant from AbbVie.

Organon has provided sponsorship towards this independent resource. Organon has had no editorial input or control over content, nor opportunity to influence.

Financial support was provided as GMG Knowledge Gap Grant from Pfizer Inc, Pfizer have provided only financial support and had no input into the content provided.

Editorial PolicyCGRP Forum is an expert resource for clinicians and healthcare professionals working with migraine patients. All patients should discuss their medication with their healthcare professional. Unless otherwise indicated, opinions expressed in the CGRP Education and Research Forum are those of the contributors. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the CGRP Forum, the editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.

© 2024 | Privacy Policy | Editorial Policy | Governance | Disclaimer Statement | Partnership & Outreach | Educational Partners and Supporters |